Optimization of Lentivirus Capture & Polishing Steps

Georgi Makin
31 March 2023
SHARE NOW
ATW
Cell Therapy
Clinical Trials
Collaborations, Mergers & Acquisitions
Gene Therapy
Partnering
Scaling Up
Strategy
This Briefing from Advanced Therapies Week 2023 focusses on the optimization of lentivirus capture and polishing steps.
During this session, Cytiva’s Michelle Hutchinson is joined by Åsa Hagner Mcwhirter and Adam Mcleod – also from Cytiva – as well as James Miskin from Oxford Biomedica.
This Briefing was presented at Advanced Therapies Week 2023, in partnership with Cytiva.
More like this
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
Lee Buckler, SVP Advanced Therapies, Blood Centers of America, Advanced Therapies Network, reflects on two decades of working within the advanced therapies industry as Phacilitate celebrates 20 years of operating in the field.
4 December 2023
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
6 December 2023
Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome
Two female pediatric patients with Rett syndrome were the first children worldwide to receive the promising treatment with Neurogene’s lead gene therapy product.
5 December 2023